[HTML][HTML] Fast and Sensitive Method for Simultaneous Quantification of Meropenem and Vaborbactam in Human Plasma Microsamples by Liquid Chromatography …
Meropenem (MRP)-Vaborbactam (VBR) is a novel beta-lactam/beta-lactamase inhibitor
used for the management of difficult-to-treat Gram-negative infections. Among critically ill …
used for the management of difficult-to-treat Gram-negative infections. Among critically ill …
Fast and Sensitive Method for Simultaneous Quantification of Meropenem and Vaborbactam in Human Plasma Microsamples by Liquid Chromatography-Tandem …
R Barone, M Conti, B Giorgi, M Gatti, PG Cojutti, P Viale… - ANTIBIOTICS, 2023 - cris.unibo.it
Abstract Meropenem (MRP)-Vaborbactam (VBR) is a novel beta-lactam/beta-lactamase
inhibitor used for the management of difficult-to-treat Gram-negative infections. Among …
inhibitor used for the management of difficult-to-treat Gram-negative infections. Among …
Fast and Sensitive Method for Simultaneous Quantification of Meropenem and Vaborbactam in Human Plasma Microsamples by Liquid Chromatography–Tandem …
R Barone, M Conti, B Giorgi, M Gatti… - Antibiotics (Basel …, 2023 - europepmc.org
Abstract Meropenem (MRP)-Vaborbactam (VBR) is a novel beta-lactam/beta-lactamase
inhibitor used for the management of difficult-to-treat Gram-negative infections. Among …
inhibitor used for the management of difficult-to-treat Gram-negative infections. Among …
Fast and sensitive method for simultaneous quantification of meropenem and vaborbactam in human plasma microsamples by liquid chromatography-tandem mass …
R Barone, M Conti, B Giorgi, M Gatti, PG Cojutti, P Viale… - 2023 - cabidigitallibrary.org
Abstract Meropenem (MRP)-Vaborbactam (VBR) is a novel beta-lactam/beta-lactamase
inhibitor used for the management of difficult-to-treat Gram-negative infections. Among …
inhibitor used for the management of difficult-to-treat Gram-negative infections. Among …
Fast and Sensitive Method for Simultaneous Quantification of Meropenem and Vaborbactam in Human Plasma Microsamples by Liquid Chromatography–Tandem …
R Barone, M Conti, B Giorgi, M Gatti, PG Cojutti… - …, 2023 - search.proquest.com
Abstract Meropenem (MRP)-Vaborbactam (VBR) is a novel beta-lactam/beta-lactamase
inhibitor used for the management of difficult-to-treat Gram-negative infections. Among …
inhibitor used for the management of difficult-to-treat Gram-negative infections. Among …
Fast and Sensitive Method for Simultaneous Quantification of Meropenem and Vaborbactam in Human Plasma Microsamples by Liquid Chromatography-Tandem …
R Barone, M Conti, B Giorgi, M Gatti… - Antibiotics (Basel …, 2023 - pubmed.ncbi.nlm.nih.gov
Meropenem (MRP)-Vaborbactam (VBR) is a novel beta-lactam/beta-lactamase inhibitor
used for the management of difficult-to-treat Gram-negative infections. Among critically ill …
used for the management of difficult-to-treat Gram-negative infections. Among critically ill …
[HTML][HTML] Fast and Sensitive Method for Simultaneous Quantification of Meropenem and Vaborbactam in Human Plasma Microsamples by Liquid Chromatography …
R Barone, M Conti, B Giorgi, M Gatti, PG Cojutti… - Antibiotics, 2023 - ncbi.nlm.nih.gov
Abstract Meropenem (MRP)-Vaborbactam (VBR) is a novel beta-lactam/beta-lactamase
inhibitor used for the management of difficult-to-treat Gram-negative infections. Among …
inhibitor used for the management of difficult-to-treat Gram-negative infections. Among …
Fast and Sensitive Method for Simultaneous Quantification of Meropenem and Vaborbactam in Human Plasma Microsamples by Liquid Chromatography–Tandem …
R Barone, M Conti, B Giorgi, M Gatti… - Antibiotics (2079 …, 2023 - search.ebscohost.com
Abstract Meropenem (MRP)-Vaborbactam (VBR) is a novel beta-lactam/beta-lactamase
inhibitor used for the management of difficult-to-treat Gram-negative infections. Among …
inhibitor used for the management of difficult-to-treat Gram-negative infections. Among …
Fast and Sensitive Method for Simultaneous Quantification of Meropenem and Vaborbactam in Human Plasma Microsamples by Liquid Chromatography-Tandem …
R Barone, M Conti, B Giorgi, M Gatti… - Antibiotics (Basel …, 2023 - europepmc.org
Meropenem (MRP)-Vaborbactam (VBR) is a novel beta-lactam/beta-lactamase inhibitor
used for the management of difficult-to-treat Gram-negative infections. Among critically ill …
used for the management of difficult-to-treat Gram-negative infections. Among critically ill …
[PDF][PDF] Fast and Sensitive Method for Simultaneous Quantification of Meropenem and Vaborbactam in Human Plasma Microsamples by Liquid Chromatography …
R Barone, M Conti, B Giorgi, M Gatti, PG Cojutti, P Viale… - 2023 - cris.unibo.it
Meropenem (MRP)-Vaborbactam (VBR) is a novel beta-lactam/beta-lactamase inhibitor
used for the management of difficult-to-treat Gram-negative infections. Among critically ill …
used for the management of difficult-to-treat Gram-negative infections. Among critically ill …